Thanks redant. I was aware of this.Is this the only thing that...

Thanks redant. I was aware of this.

Is this the only thing that has been published by Tali? This seems very light on for detail.

Trials were supposed to commence in FY22. Did they? Where is this at?
Tali were due to receive milestone paymets from Akilli in FY22. Is this still on track? What are the remaining hurdles to receive this payment?

Given that Tali's future seems to depend almost entirely on this FDA approval (and the timeline you posted above), I just would have thought that management would be providing super clear communications on how we are tracking against these milestones, and successes and failures.

I might be mistaken, but I don't think this has happened thus far. I'm hoping that the 4c will shed some more light on what is currently happening.

Am I right in saying that Tali essentially have all of their eggs in one basket? (this FDA approval). If not, what am I missing.